전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
adverse reactions were experienced by 2,256 (32.2%) of the patients treated with edoxaban 60 mg (30 mg dose reduced) in the engage af-timi 48 study and 1,249 (30.3%) in the hokusai-vte study.
kõrvaltoimeid tekkis uuringus engage af-timi 48 kokku 2256 (32,2%) patsiendil, keda raviti edoksabaani 60 mg-ga (vähendatud annusega 30 mg), ja uuringus hokusai-vte kokku 1249 (30,3%) patsiendil.